Navigating the Landscape: Local GLP-1 Suppliers and Availability in GermanyIn the last few years, the pharmaceutical landscape in Germany has seen a substantial shift with the arrival and subsequent rise in demand for Glucagon-like peptide-1 (GLP-1) receptor agonists. Originally developed to manage Type 2 diabetes, these medications-- including brand names
